Baldur Magnusson

Spiroindolone KAE609 for Falciparum and Vivax Malaria

Nicholas J. White, Sasithon Pukrittayakamee, Aung Pyae Phyo et al. · New England Journal of Medicine · 2014 · 244 citations · Full text

The oral CRTh2 antagonist QAW039 (fevipiprant): A phase II study in uncontrolled allergic asthma

Veit J. Erpenbeck, Todor A. Popov, David Miller et al. · Pulmonary Pharmacology & Therapeutics · 2016 · 108 citations

Asthma, Allergy, Uncontrolled Allergic Asthma +8

Antimalarial Activity of KAF156 in Falciparum and Vivax Malaria

Nicholas J. White, Tran Thanh Duong, Chirapong Uthaisin et al. · New England Journal of Medicine · 2016 · 107 citations · Full text

A First-in-Human Randomized, Double-Blind, Placebo-Controlled, Single- and Multiple-Ascending Oral Dose Study of Novel Antimalarial Spiroindolone KAE609 (Cipargamin) To Assess Its Safety, Tolerability, and Pharmacokinetics in Healthy Adult Volunteers

F. Joel Leong, Ruobing Li, Jay Prakash Jain et al. · Antimicrobial Agents and Chemotherapy · 2014 · 103 citations · Full text

Drug Safety, Healthy Adult Volunteers, Pharmacological Study +14

Group sequential enrichment design incorporating subgroup selection

Baldur Magnusson, Bruce W. Turnbull · Statistics in Medicine · 2013 · 85 citations